Integer Holdings Corp (ITGR) · Sep 30, 2026 · Acquisition

Integer acquisition clears HSR review, but the $5.7B deal still needs shareholder approval

HSR cleared — HSR waiting period terminated; $127-per-share cash merger remains subject to approval

Integer’s acquisition filing confirms HSR clearance for KKR’s $5.7 billion take-private deal, with the October 21 shareholder vote still ahead.

Integer is a medical-device contract development and manufacturing organization serving cardio and vascular, neuromodulation, and cardiac rhythm management markets; its immediate business story is now dominated by KKR’s announced take-private transaction rather than a new operating initiative.

The deal clears one regulatory hurdle, but the economics do not change. Early termination of the HSR waiting period satisfies one closing condition. 〔0〕 The consideration remains $127 per share in cash, representing approximately $5.7 billion of enterprise value.

This is progress, not a surprise reset. HSR clearance was a customary and anticipated step in the previously announced merger, so the filing reduces execution uncertainty modestly without changing the offer price, strategic rationale, or expected closing window. Other antitrust and foreign-investment approvals, along with stockholder approval, remain outstanding. 〔1〕

The next gating event is now clearly scheduled. Integer’s virtual special meeting is set for October 21, 2026, and the board continues to recommend that stockholders vote for the merger. 〔2〕

Bottom line: The filing confirms the KKR transaction is advancing normally, but it does not materially change the standing deal story. The shareholder vote and remaining regulatory approvals are still the meaningful execution steps.

What to watch next

Shareholder vote on merger, October 21, 2026

Original filing on SEC EDGAR

More Integer Holdings Corp news

Integer acquisition clears HSR review, but the $5.7B deal still needs shareholder approval | ITGR Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.